Mankind Pharma draws rush of buy calls on 57 per cent jump since IPO https://ift.tt/QsOFbWG

The company’s stock has surged 57 per cent since listing, driving its market value to more than $8 billion. It has already drawn nine buy ratings and one hold recommendation. That’s the most coverage in a similar span of time for an Indian stock that raised more than $500 million since November 2010.

from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/zKkZ3Bi